KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kla (KLAC) Asset Writedowns and Impairment: 2009-2025

Historic Asset Writedowns and Impairment for Kla (KLAC) over the last 13 years, with FY2025 value amounting to $239.1 million.

  • Kla's Asset Writedowns and Impairment rose 917.81% to $239.1 million in Q4 2024 from the same period last year, while for Jun 2025 it was $239.1 million, marking a year-over-year decrease of 3357.37%. This contributed to the annual value of $239.1 million for FY2025, which is 1740.19% down from last year.
  • Per Kla's latest filing, its Asset Writedowns and Impairment stood at $239.1 million for FY2025, which was down 1740.19% from $289.5 million recorded in FY2024.
  • In the past 5 years, Kla's Asset Writedowns and Impairment ranged from a high of $289.5 million in FY2024 and a low of $842000.0 during FY2021
  • Over the past 5 years, Kla's median Asset Writedowns and Impairment value was $9.9 million (recorded in 2023), while the average stood at $109.1 million.
  • As far as peak fluctuations go, Kla's Asset Writedowns and Impairment plummeted by 9368.86% in 2021, and later surged by 282250.38% in 2024.
  • Kla's Asset Writedowns and Impairment (Annual) stood at $842000.0 in 2021, then skyrocketed by 608.08% to $6.0 million in 2022, then skyrocketed by 66.14% to $9.9 million in 2023, then skyrocketed by 2822.5% to $289.5 million in 2024, then fell by 17.4% to $239.1 million in 2025.
  • Its Asset Writedowns and Impairment was $239.1 million in FY2025, compared to $289.5 million in FY2024 and $9.9 million in FY2023.